Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yu Mizote"'
Autor:
Kumiko Tatsumi, Hiroshi Wada, Shinichiro Hasegawa, Kei Asukai, Shigenori Nagata, Tomoya Ekawa, Takashi Akazawa, Yu Mizote, Shintaro Okumura, Ryosuke Okamura, Masayuki Ohue, Kazutaka Obama, Hideaki Tahara
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Background Liver injury associated with oxaliplatin (L‐OHP)‐based chemotherapy can significantly impact the treatment outcomes of patients with colorectal cancer liver metastases, especially when combined with surgery. To date, no defini
Externí odkaz:
https://doaj.org/article/1c66239c3ce244538d1351cf667e673f
Autor:
Yoichiro Harada, Yu Mizote, Takehiro Suzuki, Akiyoshi Hirayama, Satsuki Ikeda, Mikako Nishida, Toru Hiratsuka, Ayaka Ueda, Yusuke Imagawa, Kento Maeda, Yuki Ohkawa, Junko Murai, Hudson H Freeze, Eiji Miyoshi, Shigeki Higashiyama, Heiichiro Udono, Naoshi Dohmae, Hideaki Tahara, Naoyuki Taniguchi
Publikováno v:
eLife, Vol 12 (2023)
Mannose has anticancer activity that inhibits cell proliferation and enhances the efficacy of chemotherapy. How mannose exerts its anticancer activity, however, remains poorly understood. Here, using genetically engineered human cancer cells that per
Externí odkaz:
https://doaj.org/article/3060d83b96b647d589cb47315ff0fe2d
Autor:
Kenji Ikezawa, Tomoya Ekawa, Shinichiro Hasegawa, Yugo Kai, Ryoji Takada, Takuo Yamai, Nobuyasu Fukutake, Hisataka Ogawa, Takashi Akazawa, Yu Mizote, Kumiko Tatsumi, Shigenori Nagata, Kei Asukai, Hidenori Takahashi, Kazuyoshi Ohkawa, Hideaki Tahara
Publikováno v:
Endoscopy International Open, Vol 10, Iss 01, Pp E82-E87 (2022)
Background and study aims In patients with pancreatic cancer (PC), patient-derived organoid cultures can be useful tools for personalized drug selection and preclinical evaluation of novel therapies. To establish a less invasive method of creating or
Externí odkaz:
https://doaj.org/article/f1b036d543e74ca89541de746c21bc5e
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
Representative results of analyses of CD4 (A) and CD8 (B) T cells expressing T cell activation and inhibitory molecules in PBMCs from an XAGE1 (GAGED2a) antibody-positive patient, KLU456 by FACS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8cdbbdde61d4e88e9d4d3322391793
https://doi.org/10.1158/1078-0432.22460087
https://doi.org/10.1158/1078-0432.22460087
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
OS of the advanced adenocarcinoma patients with EGFRwt or EGFRmt tumors (A), and with XAGE1 (GAGED2a) antigen-positive EGFRwt or EGFRmt tumors and antibody, and XAGE1 (GAGED2a) antigen-negative EGFRmt tumors (B).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96dd30d9b654dc811d3a56eb6ea748b9
https://doi.org/10.1158/1078-0432.22460081
https://doi.org/10.1158/1078-0432.22460081
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
Supplementary Table 1A. Patient characteristics (n=145). Supplementary Table 1B. EGFR mutation types (n=44). Supplementary Table 2A. Univariate Cox regression analysis. Supplementary Table 2B. Multivariate Cox regression analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ef367b06b84e8f374798314cfc035a
https://doi.org/10.1158/1078-0432.22460069.v1
https://doi.org/10.1158/1078-0432.22460069.v1
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
Purpose: The cancer/testis antigen XAGE1 (GAGED2a) is expressed in approximately 40% of advanced lung adenocarcinomas. We investigated the clinical relevance of the XAGE1 (GAGED2a) immune responses in patients with advanced lung adenocarcinoma.Experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8945b37789aadb151a4fda5a5405ae04
https://doi.org/10.1158/1078-0432.c.6524396
https://doi.org/10.1158/1078-0432.c.6524396
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
OS of the advanced lung adenocarcinoma patients with different EGFR mutation types.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b2caacc516b9b36862c535b3903722c
https://doi.org/10.1158/1078-0432.22460078
https://doi.org/10.1158/1078-0432.22460078
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
ICS of CD4 and CD8 T cells reactive against XAGE1 (GAGED2a).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a4975b91eb4e4eaf21f1d6b2f4eb62
https://doi.org/10.1158/1078-0432.22460093.v1
https://doi.org/10.1158/1078-0432.22460093.v1
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
Supplementary Figure Legend from Prolongation of Overall Survival in Advanced Lung Adenocarcinoma Patients with the XAGE1 (GAGED2a) Antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1208395a31716ada9f574001c2bbe111
https://doi.org/10.1158/1078-0432.22460075.v1
https://doi.org/10.1158/1078-0432.22460075.v1